Transplanting Hepatitis C Positive Thoracic Organs
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, pilot safety and efficacy trial for adults who are active on the heart
or lung transplantation lists and are eligible to receive an organ from an increased risk
donor who has evidence of active or prior hepatitis C infection (HCV).
Phase:
Phase 4
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Sofosbuvir Sofosbuvir-velpatasvir drug combination Velpatasvir